Markets · 1 sources covering this

Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve

Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing ₹3,000 crore in expanding capacities, particularly for high-value CDMO services, which are projected to double their revenue share by 2030. Analysts are optimistic, raising earnings forecasts and maintaining a 'BUY' rating, anticipating continued growth across its diverse segments.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·3h ago
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve
Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing ₹3,000 crore in expanding capacities, particularly for high-value CDMO services, which are projected to double their revenue share by 2030. Analysts are optimistic, raising earnings forecasts and maintaining a 'BUY' rating, anticipating continued growth across its diverse segments.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/7d4d4180bbd33bc6b2214b9a5589c8bc5166735b"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve"></iframe>

Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve

How 1 sources are covering this

Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve

More from Markets

Gold rate today slips below $4,000 for the first time since 2025, silver price also declines. Is a bigger crash coming?

Rajesh Palviya of Axis Sec suggests JSW Infrastructure, Ind-Swift Laboratories, Welspun Living shares to buy next week

Up to 42% upside! 9 stocks Jefferies, Motilal Oswal, others started coverage on. Do you own any?

US Stock Market: Sticky inflation keeps September Fed rate hike on table despite July pause expectations

Reader

Trust & legal

Across the network